Bladder cancer accounts for nearly 170,000 deaths worldwide annually. For over 4 decades,
the systemic management of muscle‐invasive and advanced bladder cancer has primarily …

Ovarian cancer is the most lethal gynecologic malignancy. Surgery and chemotherapy are
the primary treatments for ovarian cancer; however, patients often succumb to recurrence …

Breast cancer is treated with a multidisciplinary approach involving surgical oncology,
radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in …

Breast cancer therapy involves a multidisciplinary approach comprising surgery,
radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires …

Background Anthracycline–taxane chemotherapy for early-stage breast cancer substantially
improves survival compared with no chemotherapy. However, concerns about short-term …

Background Trastuzumab improves survival in the adjuvant treatment of HER-positive breast
cancer, although combined therapy with anthracycline-based regimens has been …

Breast cancer patients with the same stage of disease can have markedly different treatment
responses and overall outcome. The strongest predictors for metastases (for example, lymph …

The idea for this book came from the time the authors spent at the Statistics and Applied
Mathematical Sciences Institute (SAMSI) in Research Triangle Park in North Carolina …

Summary Background Quinquennial overviews (1985–2000) of the randomised trials in
early breast cancer have assessed the 5 year and 10-year effects of various systemic …

Background A more accurate means of prognostication in breast cancer will improve the
selection of patients for adjuvant systemic therapy. Methods Using microarray analysis to …